Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Valentin Amrhein, Sander Greenland, Blake McShane and more than 800 signatories call for an end to hyped claims and the dismissal of possibly crucial effects.
Eric Lander, Françoise Baylis, Feng Zhang, Emmanuelle Charpentier, Paul Berg and specialists from seven countries call for an international governance framework.
Real materials rarely behave like their digital counterparts. Stability of the compounds must be part of the burden of proof for predicting the complex properties of matter, urges Alex Zunger.
Analysis reveals commercial tests for Ebola are too hard to come by in the current outbreak — sustain investment, urge Lieselotte Cnops, Kevin K. Ariën and colleagues.
A new analysis of biomedical awards over five decades shows men receive more cash and more respect for their research than women do, report Brian Uzzi and colleagues.
Set up an international platform to share data and experiences, and coordinate industrial policies and trade to conserve resources and energy, urge Yong Geng, Joseph Sarkis and Raimund Bleischwitz.
Promising immunizations for diseases that affect mostly people in low- and middle-income countries need help getting to market, urge David C. Kaslow and colleagues.